BUY Lupin Limited — Sumeet Bagadia, Choice Broking
bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·29 Sept · today
Lupin Ltd has received tentative approval from the U.S. FDA for its Apixaban oral suspension, a generic version of a drug used to reduce the risk of stroke and blood clots.
BSE · Company Update·28 Sept · yesterday
6 advisors have active short-term BUY calls on this stock, with 5 issued in the last 14 days
Advisor consensus · adjacent horizon·28 Sept · yesterday
Lupin share price is currently 'overemphasizing' a risk while 'undermining' a positive, HSBC says
NewsCnbc-Tv18·22 Sept · 1w ago
Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
NewsGoogle News·16 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.